Many Tribology Group publications are Open Access thanks to funding from the EPSRC.


BibTex format

author = {Zhan, W and Rodriguez, y Baena F and Dini, D},
doi = {10.1080/10717544.2019.1639844},
journal = {Drug Delivery},
pages = {773--781},
title = {Effect of tissue permeability and drug diffusion anisotropy on convection-enhanced delivery},
url = {},
volume = {26},
year = {2019}

RIS format (EndNote, RefMan)

AB - Although convection-enhanced delivery (CED) can successfully facilitate a bypass of the blood brain barrier, its treatment efficacy remains highly limited in clinic. This can be partially attributed to the brain anisotropic characteristics that lead to the difficulties in controlling the drug spatial distribution. Here, the responses of six different drugs to the tissue anisotropy are examined through a parametric study performed using a multiphysics model, which considers interstitial fluid flow, tissue deformation and interlinked drug transport processes in CED. The delivery outcomes are evaluated in terms of the penetration depth and delivery volume for effective therapy. Simulation results demonstrate that the effective penetration depth in a given direction can be improved with the increase of the corresponding component of anisotropic characteristics. The anisotropic tissue permeability could only reshape the drug distribution in space but has limited contribution to the total effective delivery volume. On the other hand, drugs respond in different ways to the anisotropic diffusivity. The large delivery volumes of fluorouracil, carmustine, cisplatin and doxorubicin could be achieved in relatively isotropic tissue, while paclitaxel and methotrexate are able to cover enlarged regions into anisotropic tissues. Results obtained from this study serve as a guide for the design of CED treatments.
AU - Zhan,W
AU - Rodriguez,y Baena F
AU - Dini,D
DO - 10.1080/10717544.2019.1639844
EP - 781
PY - 2019///
SN - 1071-7544
SP - 773
TI - Effect of tissue permeability and drug diffusion anisotropy on convection-enhanced delivery
T2 - Drug Delivery
UR -
UR -
UR -
VL - 26
ER -